495 related articles for article (PubMed ID: 28304392)
21. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
22. Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes.
Zhong T; He B; Li X; Lei K; Tang R; Zhao B; Li X
Diabetologia; 2024 Jan; 67(1):42-51. PubMed ID: 37889319
[TBL] [Abstract][Full Text] [Related]
23. Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring.
Barron CVM; Heenan HF; Thompson H; Chan H; Ngu J; Lunt H
Diabet Med; 2022 Mar; 39(3):e14778. PubMed ID: 34957598
[TBL] [Abstract][Full Text] [Related]
24. Glycaemic variability in diabetes: clinical and therapeutic implications.
Ceriello A; Monnier L; Owens D
Lancet Diabetes Endocrinol; 2019 Mar; 7(3):221-230. PubMed ID: 30115599
[TBL] [Abstract][Full Text] [Related]
25. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
[TBL] [Abstract][Full Text] [Related]
26. Shortfalls of the use of HbA1C-derived eAG in older adults with diabetes.
Munshi MN; Segal AR; Slyne C; Samur AA; Brooks KM; Horton ES
Diabetes Res Clin Pract; 2015 Oct; 110(1):60-65. PubMed ID: 26272739
[TBL] [Abstract][Full Text] [Related]
27. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study.
Avari P; Ramli R; Reddy M; Oliver N; Fothergill R
BMC Endocr Disord; 2019 Oct; 19(1):110. PubMed ID: 31655586
[TBL] [Abstract][Full Text] [Related]
28. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
29. HbA
Carlson AL; Criego AB; Martens TW; Bergenstal RM
Endocrinol Metab Clin North Am; 2020 Mar; 49(1):95-107. PubMed ID: 31980124
[TBL] [Abstract][Full Text] [Related]
30. Survey about do-it-yourself closed loop systems in the treatment of diabetes in Germany.
Herzog AL; Busch J; Wanner C; von Jouanne-Diedrich HK
PLoS One; 2020; 15(12):e0243465. PubMed ID: 33332410
[TBL] [Abstract][Full Text] [Related]
31. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
[TBL] [Abstract][Full Text] [Related]
32. Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice.
Davey B; Segal DG
S Afr Med J; 2015 Apr; 105(5):405-7. PubMed ID: 26242666
[TBL] [Abstract][Full Text] [Related]
33. The Glucose Measurement Industry and Hemoglobin A1c: An Opportunity for Creative Destruction.
Cembrowski G
J Diabetes Sci Technol; 2015 Oct; 10(1):72-5. PubMed ID: 26481643
[TBL] [Abstract][Full Text] [Related]
34. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
35. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
36. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
37. How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
Ajjan RA
Diabetes Technol Ther; 2017 May; 19(S2):S27-S36. PubMed ID: 28541132
[TBL] [Abstract][Full Text] [Related]
38. Correlation between self-monitored mean blood glucose and average plasma glucose estimated from glycated haemoglobin in patients attending the diabetes clinic at Dr George Mukhari Academic Hospital, Pretoria, South Africa.
Nkoana MK; Khine AA
S Afr Med J; 2020 Apr; 110(5):416-421. PubMed ID: 32657728
[TBL] [Abstract][Full Text] [Related]
39. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin.
Gomez-Peralta F; Choudhary P; Cosson E; Irace C; Rami-Merhar B; Seibold A
Diabetes Obes Metab; 2022 Apr; 24(4):599-608. PubMed ID: 34984825
[TBL] [Abstract][Full Text] [Related]
40. Benefits of the addition of continuous or flash glucose monitoring versus standard practice using self-monitored blood glucose and haemoglobin A1c in the primary care of diabetes mellitus: a systematic review protocol.
Kieu A; Govender RD; Östlundh L; King J
BMJ Open; 2021 Aug; 11(8):e050027. PubMed ID: 34446495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
